Emisphere added that it will retain its scientific staff and laboratory facilities in Tarrytown. The move to New Jersey is one of several real estate initiatives planned by the company that, cumulatively, could result in long-term savings of over $1 million. The move into these offices will be initiated November 2007 and completed by the first quarter of 2008.
Michael Novinski, president and CEO, said: “This move allows us to better serve all of our customers and enhance collaborations with leading pharmaceutical companies. The move will keep Emisphere agile and competitive for our partners, and be particularly advantageous as we take the company in new and exciting directions.”